835 related articles for article (PubMed ID: 14734742)
21. Thymoquinone inhibits TNF-α-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation.
Umar S; Hedaya O; Singh AK; Ahmed S
Toxicol Appl Pharmacol; 2015 Sep; 287(3):299-305. PubMed ID: 26134265
[TBL] [Abstract][Full Text] [Related]
22. Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-terminal kinase pathway.
Lee SI; Boyle DL; Berdeja A; Firestein GS
Arthritis Res Ther; 2012 Feb; 14(1):R38. PubMed ID: 22353730
[TBL] [Abstract][Full Text] [Related]
23. Role of p21-activated kinase 1 in regulating the migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients.
Fu D; Yang Y; Xiao Y; Lin H; Ye Y; Zhan Z; Liang L; Yang X; Sun L; Xu H
Rheumatology (Oxford); 2012 Jul; 51(7):1170-80. PubMed ID: 22416254
[TBL] [Abstract][Full Text] [Related]
24. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
25. A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes.
Cha HS; Boyle DL; Inoue T; Schoot R; Tak PP; Pine P; Firestein GS
J Pharmacol Exp Ther; 2006 May; 317(2):571-8. PubMed ID: 16452391
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: involvement of ERK, JNK, AP-1, and NF-kappaB.
Yang CM; Luo SF; Hsieh HL; Chi PL; Lin CC; Wu CC; Hsiao LD
J Cell Physiol; 2010 Aug; 224(2):516-26. PubMed ID: 20432452
[TBL] [Abstract][Full Text] [Related]
27. Synoviocyte innate immune responses: I. Differential regulation of interferon responses and the JNK pathway by MAPK kinases.
Yoshizawa T; Hammaker D; Sweeney SE; Boyle DL; Firestein GS
J Immunol; 2008 Sep; 181(5):3252-8. PubMed ID: 18713996
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts.
Geurts J; van den Brand BT; Wolf A; Abdollahi-Roodsaz S; Arntz OJ; Kracht M; van den Berg WB; van de Loo FA
Rheumatology (Oxford); 2011 Jul; 50(7):1216-25. PubMed ID: 21335610
[TBL] [Abstract][Full Text] [Related]
29. Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis.
Kunisch E; Gandesiri M; Fuhrmann R; Roth A; Winter R; Kinne RW
Ann Rheum Dis; 2007 Aug; 66(8):1043-51. PubMed ID: 17223661
[TBL] [Abstract][Full Text] [Related]
30. Mutations in protein kinase subdomain X differentially affect MEKK2 and MEKK1 activity.
Huang J; Tu Z; Lee FS
Biochem Biophys Res Commun; 2003 Apr; 303(2):532-40. PubMed ID: 12659851
[TBL] [Abstract][Full Text] [Related]
31. Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation.
Cheng J; Yang J; Xia Y; Karin M; Su B
Mol Cell Biol; 2000 Apr; 20(7):2334-42. PubMed ID: 10713157
[TBL] [Abstract][Full Text] [Related]
32. Secreted frizzled-related protein 5 suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes through down-regulation of c-Jun N-terminal kinase.
Kwon YJ; Lee SW; Park YB; Lee SK; Park MC
Rheumatology (Oxford); 2014 Sep; 53(9):1704-11. PubMed ID: 24764263
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
[TBL] [Abstract][Full Text] [Related]
34. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.
Sun W; Kesavan K; Schaefer BC; Garrington TP; Ware M; Johnson NL; Gelfand EW; Johnson GL
J Biol Chem; 2001 Feb; 276(7):5093-100. PubMed ID: 11073940
[TBL] [Abstract][Full Text] [Related]
35. MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42.
Fanger GR; Johnson NL; Johnson GL
EMBO J; 1997 Aug; 16(16):4961-72. PubMed ID: 9305638
[TBL] [Abstract][Full Text] [Related]
36. MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells.
Garrington TP; Ishizuka T; Papst PJ; Chayama K; Webb S; Yujiri T; Sun W; Sather S; Russell DM; Gibson SB; Keller G; Gelfand EW; Johnson GL
EMBO J; 2000 Oct; 19(20):5387-95. PubMed ID: 11032806
[TBL] [Abstract][Full Text] [Related]
37. Regulation of JNK by MKK-7 in fibroblast-like synoviocytes.
Inoue T; Hammaker D; Boyle DL; Firestein GS
Arthritis Rheum; 2006 Jul; 54(7):2127-35. PubMed ID: 16802349
[TBL] [Abstract][Full Text] [Related]
38. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
[TBL] [Abstract][Full Text] [Related]
39. Cloning of DPK, a novel dendritic cell-derived protein kinase activating the ERK1/ERK2 and JNK/SAPK pathways.
Zhang W; Chen T; Wan T; He L; Li N; Yuan Z; Cao X
Biochem Biophys Res Commun; 2000 Aug; 274(3):872-9. PubMed ID: 10924369
[TBL] [Abstract][Full Text] [Related]
40. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.
Muniyappa H; Das KC
Cell Signal; 2008 Apr; 20(4):675-83. PubMed ID: 18222647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
